BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32511854)

  • 1. Prophylactic Strategy Against De Novo Hepatitis B Virus Infection for Pediatric Recipients Who Receive Hepatitis B Core Antibody-Positive Liver Grafts.
    Song Z; Dong C; Meng X; Sun C; Wang K; Qin H; Han C; Yang Y; Zhang F; Zheng W; Chen J; Duan K; Bi B; Gao W
    Liver Transpl; 2021 Jan; 27(1):96-105. PubMed ID: 32511854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors of de novo hepatitis B virus infection in pediatric hepatitis B core antibody positive liver graft recipients under prophylactic therapy.
    Dong C; Song Z; Chen J; Ma N; Meng X; Sun C; Duan K; Bi B; Wang K; Qin H; Han C; Yang Y; Zhang F; Zheng W; Gao W
    J Gastroenterol Hepatol; 2020 May; 35(5):827-832. PubMed ID: 31609494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo hepatitis b prophylaxis with hepatitis B virus vaccine and hepatitis B immunoglobulin in pediatric recipients of core antibody-positive livers.
    Lee S; Kim JM; Choi GS; Park JB; Kwon CH; Choe YH; Joh JW; Lee SK
    Liver Transpl; 2016 Feb; 22(2):247-51. PubMed ID: 26600319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of hepatitis B virus core antibody-positive grafts in liver transplantation: A single-center experience in China.
    Lei M; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Wu H; Xu MQ; Chen ZY; Wei YG
    World J Gastroenterol; 2018 Dec; 24(48):5525-5536. PubMed ID: 30622380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Application of active immunization in the prevention of de novo hepatitis B virus infection after pediatric liver transplantation with HBcAb positive donor liver].
    Cui Y; Lu W; Gao W; Dong C; Han C; Liu Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Oct; 29(10):926-930. PubMed ID: 29017655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HBsAg seroconversion in de novo hepatitis B virus-infected paediatric liver transplant recipients with anti-viral therapy.
    Dong C; Song Z; Sun C; Wang K; Chen J; Zhang W; Wu D; Zheng W; Yang Y; Qin H; Han C; Zhang F; Wang Z; Xu M; Zhang G; Xie E; Jiao J; Cao S; Gao W; Shen Z
    J Viral Hepat; 2022 Dec; 29(12):1099-1106. PubMed ID: 36094676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of de novo hepatitis B with adefovir dipivoxil in recipients of liver grafts from hepatitis B core antibody-positive donors.
    Chang MS; Olsen SK; Pichardo EM; Heese S; Stiles JB; Abdelmessih R; Verna EC; Guarrera JV; Emond JC; Brown RS
    Liver Transpl; 2012 Jul; 18(7):834-8. PubMed ID: 22422699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for de novo hepatitis B infection in pediatric living donor liver transplantation.
    Rao W; Xie M; Yang T; Zhang JJ; Gao W; Deng YL; Zheng H; Pan C; Liu YH; Shen ZY
    World J Gastroenterol; 2014 Sep; 20(36):13159-66. PubMed ID: 25278711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of de novo hepatitis B in recipients of core antibody-positive livers with lamivudine and other nucleos(t)ides: a 12-year experience.
    Chang MS; Olsen SK; Pichardo EM; Stiles JB; Rosenthal-Cogan L; Brubaker WD; Guarrera JV; Emond JC; Brown RS
    Transplantation; 2013 Apr; 95(7):960-5. PubMed ID: 23545507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of de novo hepatitis in liver recipients from hepatitis-B core antibody-positive grafts - a systematic analysis.
    Skagen CL; Jou JH; Said A
    Clin Transplant; 2011; 25(3):E243-9. PubMed ID: 21323735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of de novo hepatitis B infection from HbcAb-positive donors in living donor liver transplantation.
    Lee KW; Lee DS; Lee HH; Kim SJ; Joh JW; Seo JM; Choe YH; Lee SK
    Transplant Proc; 2004 Oct; 36(8):2311-2. PubMed ID: 15561233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors.
    Prakoso E; Strasser SI; Koorey DJ; Verran D; McCaughan GW
    Clin Transplant; 2006; 20(3):369-73. PubMed ID: 16824156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De Novo Hepatitis B Virus Infection After Liver Transplantation in Hepatitis B Core-positive Recipients Using Hepatitis B Core-negative Grafts.
    Nugroho A; Lee KW; Kim H; Yi NJ; Suh KS
    Transplant Proc; 2019 Apr; 51(3):842-844. PubMed ID: 30979473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of hepatitis B virus infection from hepatitis B core antibody-positive donor graft using hepatitis B immune globulin and lamivudine in living donor liver transplantation.
    Suehiro T; Shimada M; Kishikawa K; Shimura T; Soejima Y; Yoshizumi T; Hashimoto K; Mochida Y; Maehara Y; Kuwano H
    Liver Int; 2005 Dec; 25(6):1169-74. PubMed ID: 16343068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hepatitis B surface antibody in patients with core antibody-positive liver transplantation: a systematic review and meta-analysis.
    Yang Y; Huang A; Zhao Y
    Hepatol Int; 2020 Mar; 14(2):202-211. PubMed ID: 32100260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risks and treatment strategies for de novo hepatitis B virus infection from anti-HBc-positive donors in pediatric living donor liver transplantation.
    Dong C; Gao W; Ma N; Sun C; Zheng WP; Wang K; Shen ZY
    Pediatr Transplant; 2017 Mar; 21(2):. PubMed ID: 27933716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risks of HBV infection after liver transplantation from HBc antibody positive donor to HBs antibody positive recipient.
    Ikegami T; Taketomi A; Ohta R; Soejima Y; Yoshizumi T; Harada N; Shimada M; Maehara Y
    Hepatogastroenterology; 2008; 55(88):2162-5. PubMed ID: 19260497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active vaccination to prevent de novo hepatitis B virus infection in liver transplantation.
    Lin CC; Yong CC; Chen CL
    World J Gastroenterol; 2015 Oct; 21(39):11112-7. PubMed ID: 26494965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B immunoglobulin prophylaxis for
    Jung HS; Choi Y; Yoon KC; Hong SY; Suh S; Hong K; Han ES; Lee JM; Hong SK; Yi NJ; Lee KW; Suh KS
    Ann Transl Med; 2022 Mar; 10(5):243. PubMed ID: 35402602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver transplantation in hepatitis B core-negative recipients using livers from hepatitis B core-positive donors: a 13-year experience.
    Bohorquez HE; Cohen AJ; Girgrah N; Bruce DS; Carmody IC; Joshi S; Reichman TW; Therapondos G; Mason AL; Loss GE
    Liver Transpl; 2013 Jun; 19(6):611-8. PubMed ID: 23526668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.